XENE Xenon Pharmaceuticals Inc.

Fundamentals / CIK 0001582313 / USD

Xenon Pharmaceuticals Inc. reported $0 in revenue and a net loss of $428.7M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XENE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$68.23M$34.12M$0-$326.2MFY 2016 Revenue: $1.80MFY 2016 Net Income: -$23.00M2016FY 2017 Revenue: $311KFY 2017 Net Income: -$30.70M2017FY 2018 Net Income: -$34.50M2018FY 2019 Revenue: $6.83MFY 2019 Net Income: -$41.59M2019FY 2020 Revenue: $32.17MFY 2020 Net Income: -$28.84M2020FY 2021 Revenue: $18.44MFY 2021 Net Income: -$78.88M2021FY 2022 Revenue: $9.43MFY 2022 Net Income: -$125.4M2022FY 2023 Revenue: $0FY 2023 Net Income: -$182.4M2023FY 2024 Revenue: $0FY 2024 Net Income: -$234.3M2024FY 2025 Revenue: $7.50MFY 2025 Net Income: -$345.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $7.50M $0 $0 $9.43M $18.44M $32.17M $6.83M -- $311K $1.80M
Research & Development $300.9M $210.4M $167.5M $105.8M $75.46M $50.52M $38.84M $23.63M $25.57M $19.83M
Total Operating Expenses $380.6M $279.3M $214.1M $138.6M $97.43M $63.47M $49.65M $38.04M $32.89M $26.62M
Operating Income -$373.1M -$279.3M -$214.1M -$129.1M -$78.99M -$31.30M -$42.82M -$38.04M -$32.58M -$24.82M
EBITDA -$370.5M -$276.7M -$212.0M -$127.7M -$78.09M -$30.66M -$42.39M -$37.45M -$31.93M -$23.95M
Interest Income $26.83M $41.94M $27.62M $8.71M $466K $2.28M $2.35M $1.22M $477K $504K
Interest Expense -- -- -- -- -- $484K $1.43M $1.39M -- --
Income Before Tax -$344.9M -$238.4M -$182.7M -$125.3M -$78.89M -$29.09M -$41.62M -$34.52M -- --
Income Tax Expense $1.02M -$4.09M -$292K $118K -$6.0K -$257K -$23K -$24K -- --
Net Income -$345.9M -$234.3M -$182.4M -$125.4M -$78.88M -$28.84M -$41.59M -$34.50M -$30.70M -$23.00M
Basic EPS -$4.36 -$3.01 -$2.73 -$2.06 -$1.77 -$0.81 -$1.54 -$1.63 -$1.71 -$1.48
Diluted EPS -$4.36 -$3.01 -$2.73 -$2.06 -$1.77 -$0.81 -$1.54 -$1.63 -$1.72 -$1.48
Basic Shares Outstanding 79.3M 77.9M 66.9M 60.5M 43.6M 34.5M 25.9M 19.4M 18.0M 15.5M
Diluted Shares Outstanding 79.3M 77.9M 66.9M 60.5M 43.6M 34.5M 25.9M 19.4M 18.0M 15.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $7.50M $0
Research & Development $95.64M $99.22M $88.51M $87.70M $77.05M $74.98M $61.20M $59.47M
Total Operating Expenses $120.1M $123.2M $112.3M $109.8M $96.34M $94.23M $80.24M $77.48M
Operating Income -$120.1M -$123.2M -$112.3M -$109.8M -$96.34M -$94.23M -$72.74M -$77.48M
EBITDA -$119.5M -$122.6M -$111.7M -$109.2M -$95.69M -$93.60M -$72.08M -$76.81M
Interest Income $11.62M $12.14M $6.91M $5.34M $6.21M $7.20M $8.08M $9.42M
Income Before Tax -$108.6M -$111.3M -$104.9M -$104.7M -$90.22M -$85.33M -$64.62M -$69.53M
Income Tax Expense $1.84M -$585K -$2.57M $538K $677K -$626K $427K -$3.85M
Net Income -$110.4M -$110.7M -$102.3M -$105.3M -$90.90M -$84.71M -$65.05M -$65.69M
Basic EPS -$1.11 -$1.11 -$1.17 -- -$1.15 -$1.07 -$0.83 --
Diluted EPS -$1.11 -$1.11 -$1.17 -- -$1.15 -$1.07 -$0.83 --
Basic Shares Outstanding 99.8M 99.6M 87.3M -- 79.2M 79.0M 78.7M --
Diluted Shares Outstanding 99.8M 99.6M 87.3M -- 79.2M 79.0M 78.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $199.2M $142.7M $148.6M $57.24M $175.7M $45.01M $24.75M $67.75M $20.49M $17.09M
Short-Term Investments $349.7M $484.2M $489.4M $534.8M $376.1M $132.0M $116.6M $51.55M $23.18M $47.05M
Cash & Short-Term Investments $548.9M $626.9M $638.1M $592.1M $551.8M $177.0M $141.4M $119.3M $43.67M $64.15M
Accounts Receivable, Net -- $1.47M $874K $986K $2.77M $1.82M $813K $151K $438K $200K
Total Current Assets $560.6M $635.3M $645.0M $600.3M $559.0M $181.8M $144.9M $121.3M $44.82M $65.67M
Property, Plant & Equipment, Net $8.72M $10.28M $9.65M $6.50M $4.47M $3.55M $1.66M $991K $1.07M $1.40M
Long-Term Investments $37.15M $127.5M $292.8M $128.7M $0 -- -- -- -- --
Total Non-Current Assets $72.51M $162.9M $319.8M $153.8M $12.99M $7.40M $2.83M $1.10M $1.30M $1.81M
Total Assets $633.2M $798.1M $964.8M $754.1M $572.0M $189.2M $147.7M $122.4M $46.12M $67.49M
Accounts Payable $3.88M $5.07M $8.60M $8.49M $3.82M $3.04M $2.47M $665K $1.25M $1.46M
Short-Term Debt -- -- -- -- -- -- $4.65M -- $700K --
Deferred Revenue (Current) -- -- -- -- -- $3.64M $29.74M -- -- --
Total Current Liabilities $41.79M $35.59M $27.27M $22.70M $14.32M $14.78M $43.38M $4.12M $4.08M $3.59M
Long-Term Debt -- -- -- -- -- -- $10.89M $15.01M $6.10M --
Deferred Revenue (Non-Current) -- -- -- -- -- -- $709K -- -- --
Other Non-Current Liabilities $3.20M $0 -- -- -- -- -- -- -- --
Total Non-Current Liabilities $9.61M $7.65M $9.60M $9.95M $7.65M $3.05M $12.34M $15.01M $6.10M $0
Total Liabilities $51.40M $43.24M $36.88M $32.65M $21.97M $17.83M $55.72M $19.13M $10.19M $3.59M
Total Debt (incl. Leases) $7.94M $9.02M $10.90M $10.44M $8.26M $3.31M $16.45M $15.01M $6.80M --
Common Stock $1.60B $1.46B $1.44B $1.07B $783.2M $397.7M $294.2M $265.9M $173.8M $173.2M
Retained Earnings -$1.25B -$899.5M -$665.1M -$482.7M -$357.4M -$278.5M -$249.7M -$207.9M -$173.4M -$142.7M
Accumulated Other Comp. Income $335K -$1.61M -$77K -$3.00M -$990K -$990K -$990K -$990K -$990K -$990K
Total Stockholders' Equity $581.8M $754.9M $927.9M $721.5M $550.0M $171.4M $91.98M $103.3M $35.93M $63.90M
Total Equity $581.8M $754.9M $927.9M $721.5M $550.0M $171.4M $91.98M $103.3M $35.93M $63.90M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $82.56M $119.5M $545.9M $199.2M $104.5M $135.4M $116.7M $142.7M
Short-Term Investments $868.2M $811.2M $548.9M $349.7M $357.8M $352.2M $433.0M $484.2M
Cash & Short-Term Investments $950.8M $930.7M $1.09B $548.9M $462.3M $487.5M $549.6M $626.9M
Accounts Receivable, Net -- -- -- -- -- -- -- $1.47M
Total Current Assets $960.1M $945.9M $1.11B $560.6M $480.1M $500.3M $565.5M $635.3M
Property, Plant & Equipment, Net $7.46M $7.77M $8.29M $8.72M $8.89M $9.21M $9.70M $10.28M
Long-Term Investments $202.7M $314.4M $244.9M $37.15M $92.99M $137.3M $141.5M $127.5M
Total Non-Current Assets $239.8M $349.9M $280.2M $72.51M $127.7M $174.0M $177.7M $162.9M
Total Assets $1.20B $1.30B $1.39B $633.2M $607.8M $674.3M $743.3M $798.1M
Accounts Payable $1.93M $2.48M $5.75M $3.88M $4.55M $4.79M $6.88M $5.07M
Total Current Liabilities $45.30M $45.01M $39.81M $41.79M $38.34M $33.05M $32.03M $35.59M
Other Non-Current Liabilities $3.33M $3.29M $3.25M $3.20M $3.16M -- -- $0
Total Non-Current Liabilities $8.19M $8.37M $9.18M $9.61M $9.99M $7.26M $7.29M $7.65M
Total Liabilities $53.49M $53.38M $48.99M $51.40M $48.33M $40.30M $39.32M $43.24M
Total Debt (incl. Leases) $6.01M $6.42M $7.49M $7.94M $8.33M $8.71M $8.68M $9.02M
Common Stock $2.49B $2.43B $2.42B $1.60B $1.48B $1.47B $1.46B $1.46B
Retained Earnings -$1.57B -$1.46B -$1.35B -$1.25B -$1.14B -$1.05B -$964.5M -$899.5M
Accumulated Other Comp. Income -$5.05M -$2.66M -$1.21M $335K $477K $113K -$836K -$1.61M
Total Stockholders' Equity $1.15B $1.24B $1.34B $581.8M $559.5M $634.0M $704.0M $754.9M
Total Equity $1.15B $1.24B $1.34B $581.8M $559.5M $634.0M $704.0M $754.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$345.9M -$234.3M -$182.4M -$125.4M -$78.88M -$28.84M -$41.59M -$34.50M -$30.70M -$23.00M
Depreciation & Amortization $2.54M $2.56M $2.06M $1.41M $906K $644K $429K $586K $649K $864K
Stock-Based Compensation $53.71M $50.72M $32.37M $20.38M $10.02M $5.68M $2.92M $2.62M $2.24M $2.16M
Change in Receivables -- -$614K $130K $1.76M -$459K -$1.03M -$653K $280K -$232K $121K
Operating Cash Flow -$279.1M -$181.4M -$151.1M -$101.0M -$69.50M -$48.12M -$4.71M -$34.72M -$28.73M -$19.57M
Capital Expenditure -$799K -$3.08M -$5.62M -$2.89M -$2.05M -$2.64M -$1.24M -$507K -$315K -$279K
Free Cash Flow -$279.9M -$184.5M -$156.7M -$103.9M -$71.55M -$50.76M -$5.95M -$35.23M -$29.04M -$19.85M
Purchases of Investments -$355.7M -$532.3M -$793.9M -$551.1M -$389.5M -$228.9M -$140.5M -$77.00M -$28.01M -$47.56M
Investing Cash Flow $218.0M $165.0M -$111.4M -$293.4M -$246.8M -$16.82M -$66.21M -$28.99M $24.29M -$47.84M
Common Stock Issued -- -- -- -- -- $102.5M $27.40M $102.8M -- $23.83M
Financing Cash Flow $117.1M $12.13M $353.5M $278.5M $447.5M $85.80M $27.52M $111.6M $7.07M $23.96M
Net Change in Cash $56.45M -$5.93M $91.40M -$118.4M $130.7M $20.25M -$43.00M $47.27M $3.39M -$41.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$110.4M -$110.7M -$102.3M -$105.3M -$90.90M -$84.71M -$65.05M -$65.69M
Depreciation & Amortization $562K $558K $587K $611K $641K $632K $659K $666K
Stock-Based Compensation $16.55M $16.73M $16.89M $14.12M $13.71M $13.71M $12.17M $13.60M
Change in Receivables -- -- -- -- -- -- -- -$547K
Operating Cash Flow -$90.33M -$95.39M -$88.90M -$81.48M -$71.75M -$64.23M -$61.65M -$54.38M
Capital Expenditure -$284K -$275K -$133K -$318K -$281K -$157K -$43K -$783K
Free Cash Flow -$90.61M -$95.67M -$89.03M -$81.80M -$72.03M -$64.39M -$61.70M -$55.17M
Purchases of Investments -$169.6M -$490.4M -$505.7M -$60.90M -$74.70M -$88.82M -$131.2M -$66.35M
Investing Cash Flow $53.19M -$331.2M -$407.3M $62.70M $38.53M $82.26M $34.51M $98.50M
Financing Cash Flow $228K $26K $843.0M $113.5M $2.36M $65K $1.15M $12.13M
Net Change in Cash -$36.97M -$426.3M $346.7M $94.65M -$30.87M $18.72M -$26.05M $55.09M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -4974.3% -- -- -1368.9% -428.4% -97.3% -627.0% -- -10474.3% -1376.4%
Net Profit Margin -4612.1% -- -- -1328.9% -427.8% -89.7% -609.1% -- -9872.7% -1275.5%
Return on Equity (ROE) -59.5% -31.0% -19.7% -17.4% -14.3% -16.8% -45.2% -33.4% -85.4% -36.0%
Return on Assets (ROA) -54.6% -29.4% -18.9% -16.6% -13.8% -15.2% -28.2% -28.2% -66.6% -34.1%
Current Ratio 13.42x 17.85x 23.65x 26.44x 39.03x 12.30x 3.34x 29.46x 10.98x 18.31x
Quick Ratio 13.13x 17.66x 23.43x 26.12x 38.72x 12.10x 3.28x 29.00x 10.80x 17.94x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.02x 0.02x 0.18x 0.15x 0.19x --
Revenue Growth (YoY) -- -- -100.0% -48.8% -42.7% +371.0% -- -- -82.8% -88.4%
5Y Revenue / Share Growth -89.8% -100.0% -- +801.1% +263.1% -14.6% -97.1% -- -99.8% --
10Y Revenue / Share Growth -91.3% -100.0% -100.0% -98.6% -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -139.0% -119.7% -- --
10Y Net Income / Share Growth -- -173.2% -130.3% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -4974.3% -4543.7% -4241.6% -3906.6% --
Net Profit Margin -- -- -- -4612.1% -4084.5% -3709.7% -3352.6% --
Return on Equity (ROE) -37.4% -32.9% -28.6% -59.5% -54.8% -43.9% -35.7% -31.0%
Return on Assets (ROA) -35.7% -31.6% -27.6% -54.6% -50.4% -41.3% -33.8% -29.4%
Current Ratio 21.19x 21.02x 27.79x 13.42x 12.52x 15.14x 17.66x 17.85x
Quick Ratio 20.99x 20.68x 27.50x 13.13x 12.06x 14.75x 17.16x 17.66x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x
Revenue Growth (YoY) -- -- -100.0% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001582313) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal